KIN - Kindred Biosciences - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Kindred Biosciences's activity chart (see below) currently has 37 price targets and 34 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 46.35% with an average time for these price targets to be met of 177.62 days.

Most recent stock forecast was given by BEN HAYNOR from ALLIANCE GLOBAL PARTNERS on 23-Aug-2021. First documented stock forecast 15-Nov-2015.

Best performing analysts who are covering KIN - Kindred Biosciences:

Ben Haynor Swayampakula Ramakanth Kevin Degeeter Balaji Prasad

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 23-May-2019

$9

$-0.25 (-2.70%)

$13

Show more analysts

Please expand the browser size to see the chart

What is KIN (Kindred Biosciences) average time for price targets to be met?

On average it took 177.62 days on average for the stock forecasts to be realized with a an average price target met ratio 46.35

Which analyst has the current highest performing score on KIN (Kindred Biosciences) with a proven track record?

BEN HAYNOR

Which analyst has the most public recommendations on KIN (Kindred Biosciences)?

Ben Haynor works at LAKE STREET and has 2 price targets and 2 ratings on KIN

Which analyst is the currently most bullish on KIN (Kindred Biosciences)?

Brooks O'neil with highest potential upside - $2.75

Which analyst is the currently most reserved on KIN (Kindred Biosciences)?

Andrew D'silva with lowest potential downside - -$0.75

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?